Rockwell Medical(RMTI) - 2025 Q1 - Quarterly Results

Financial Performance - Rockwell Medical reported net sales of $18.9 million for Q1 2025, a 17$22.7 million in Q1 2024[5] - Gross profit for Q1 2025 was $3.0 million, consistent with the same period in 2024, resulting in a gross margin of 16$1.5 million, representing a 12% improvement over the net loss of $1.7 million in Q1 2024[6] - Adjusted EBITDA for Q1 2025 was ($0.4) million, slightly negative due to seasonal payroll tax and public company expenses[6] - Cash and cash equivalents decreased to $17.3 million as of March 31, 2025, down from$21.6 million at the end of 2024[6] - Total stockholders' equity increased to $31.5 million as of March 31, 2025, compared to$20.6 million in the same period in 2024[22] Future Guidance - Rockwell Medical confirmed its 2025 annual guidance, projecting net sales between $65.0 million and$70.0 million, with a gross margin of 16% to 18%[11] Product Development - The company added a single-use bicarbonate cartridge to its product portfolio through a distribution agreement with a leading medical equipment manufacturer[12] Company Recognition - Rockwell Medical was recognized as a Great Place to Work for the third consecutive year, highlighting its commitment to fostering a supportive workplace[12] Customer Impact - The largest customer transition to another supplier contributed to the decrease in net sales, although a one-time payment of $0.9 million was received to ensure product supply continuity[6]